Form 4: HealthEquity Director Acquires Shares
Statement of Changes in Beneficial Ownership
HealthEquity, Inc. Director Adrian T. Dillon acquired 2,877 shares of common stock on June 25, 2026.
Summary
- Adrian T. Dillon, a Director at HealthEquity, Inc., acquired 2,877 shares of common stock on June 25, 2026.
- The acquisition was made at a price of $0, indicating these were likely granted or awarded shares.
- Following this transaction, Mr. Dillon beneficially owns 62,395 shares of common stock.
- The filing also details Mr. Dillon's holdings of various stock options with exercise prices ranging from $32.50 to $66.06, all of which are immediately exercisable.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, as it reports a routine transaction by a director and does not contain new financial information or strategic updates.
Positives
- Director acquisition of shares can signal confidence in the company's future prospects.
- Mr. Dillon's beneficial ownership remains substantial at 62,395 shares after the acquisition.
- The acquisition of 2,877 shares at $0 cost suggests an award or grant, potentially part of executive compensation.
Future Outlook
The filing does not contain forward-looking statements or guidance. It solely reports a change in beneficial ownership.
Industry Context
StockSavvy.ai notes that Form 4 filings, like this one from HealthEquity, Inc., are standard disclosures for insider transactions. Acquisitions of stock by directors, especially at zero cost, are often part of compensation packages and can be viewed positively by the market as a sign of management's commitment.
Stakeholder Impact
- Shareholders: The acquisition by a director may be perceived positively, indicating insider confidence, but does not directly impact share price without further context.
Next Steps
- Vesting of restricted stock units on the earlier of June 25, 2027, or the issuer's next annual stockholder meeting in June 2027.
Key Dates
| Date | Description |
|---|---|
| 02/05/2024 | Date Power of Attorney was previously filed with the SEC. |
| 06/25/2026 | Date of transaction: Acquisition of 2,877 shares of common stock. |
| 06/25/2027 | Vesting date for restricted stock units. |
| 06/2027 | Date of issuer's next annual stockholder meeting, which could trigger vesting of restricted stock units. |
Keywords
HealthEquity, HQY, Form 4, Insider Trading, Stock Acquisition, Director, Securities Ownership, Stock Options
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.